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This Frontiers Research Topic, “Stem Cell Genetic Fidelity,” is
the product of an attempt to develop a comprehensive integra-
tive treatment of the historical progression of ideas and research
advances on the topic of biological mechanisms of gene muta-
tion control in tissue stem cells, with human tissues as a primary
interest. In retrospect, this undertaking began with a somewhat
ambitious goal for achievement—beginning with its need to
recruit authors diverse in both research discipline and genera-
tion. In this regard, the scientific characteristics of the final set
of contributors are noteworthy. Although many more prospec-
tive authors were invited who work in primarily experimental
research disciplines relevant to the topic, in the end these are
underrepresented in the final volume. The ones for whom this
volume’s focus was an effective attractor constitute a select set of
cell biologists and molecular biologists whose search for funda-
mental principles of tissue stem cell biology is driven as much by
theoretical modeling approaches as by experimentation.
The deployment of modeling strategies by investigators of
the biological principles of genetic fidelity in mammalian tis-
sue stem cells is consistent with the challenges presented by this
research. The low tissue fractions of stem cells and the low frac-
tions of themutations they incur combine to present investigation
challenges that defy ideal quantitative analyses. Yet, at the same
time, the intrinsic cascades of stem cell-based tissue cell lineages
and molecular gene expression hierarchies synergistically amplify
minute genetic-cellular deviations in ways that can profoundly
influence life and health.
The final cast of contributors is well suited to achieving a par-
ticular goal of this Research Topic, which is to bring attention
to remarkable advances in cell biology thought that flow from
the theoretical genius of four giants in stem cell genetic fidelity
research, Lark, Cairns, Potten, and Knudson. Though all applied
observation and experimentation for discovering fundamental
biological principles, they also employed elegant theoretical mod-
eling as a fine tool for exploring and predicting the workings
of tissue cells ahead of experimental approaches and confirma-
tion. Lark, Cairns, and Potten are the most tightly woven into
the fabric of ideas on the importance of tissue stem cell genetic
fidelity in normal tissue function and carcinogenesis as a result
to their shared contributions to the immortal strand hypothesis
(Cairns, 1975). Subsequently, Knudson’s two hit hypothesis gave
wings to the idea that a key rate limiting factor for the emer-
gence of tumors was two mutations, not only in the alleles of
the same gene, but implicitly in the same cell; and most aptly a
tissue stem cell (Knudson, 1992). The work of these remarkable
tissue cell biologists—undertaken at the median of stem cell biol-
ogy history—set the paradigms for current and future research
to discover the biological and evolutionary significance of stem
cell genetic fidelity mechanisms. In “Stem Cell Genetic Fidelity,”
Lark provides a personal account of the key experimental obser-
vation that initiated the field of stem cell genetic fidelity research
(Lark et al., 1966). As will be noted in reading the Research Topic,
several of the contributed articles are descendants of his seminal
contribution.
Here, I join Lark with a somewhat personal account of my
own that further builds the context for this Frontiers Research
Topic. In the fall 1978 as a new student of cancer research, like
many before and after, I set myself on a path to “find a cure for
cancer.” However, I was more intrigued with mastering the new
DNA maps of transforming viral genomes than the changes that
they induced in cells. My studies occurred in the last days before
the emergence of the concept that cancer was caused by muta-
tions in cellular genes that resembled the oncogenes carried by
tumor-forming viruses. Of course, the tenet that gene mutation
was an essential aspect of the carcinogenic mechanism was well
established long before the first human cancer gene was identi-
fied. So, years before I was drawn to cancer research, many cancer
scientists were thinking about how carcinogenic mutations arose.
However, there was only one who was asking why there were
not more carcinogenic mutations, and correspondingly a higher
incidence of human cancers. John Cairns.
In his 1975 report (Cairns, 1975) on the natural history of
human cancers, Cairns introduced the fundamental idea of tissue
stem cell genetic fidelity and set inmotion the essential hypothesis
that would trouble the thoughts of cancer scientists and a paral-
lel universe of stem cell biologists for years to come. His proposal
that mammalian tissue stem cells must have a unique mechanism
to lower their rate of carcinogenic mutation continues to be a
disruptive idea in both stem cell biology and cancer biology.
The blade of Cairns’ hypothesis has two sharp edges. First,
the “immortal strand hypothesis” cuts through apparent tissue
cells and attributes the cell of origin for cancer to tissue stem
cells, which are generally physically elusive. Second, the proposed
molecular basis for the hypothesis, non-random sister chromatid
segregation, slices through geneticists’ essential Mendelian laws
of mitotic chromosome segregation. Cairns proposed that asym-
metrically cycling tissue stem cells ignored Mendel’s previously
immutable laws of random assortment and independent segrega-
tion. By non-random co-segregation of the complement of sister
chromatids with the older template DNA strands, Cairns saw that
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asymmetrically cycling tissue stem cells could avoid DNA replica-
tion errors, which he predicted to be the most frequent source of
carcinogenic mutations.
Cairns’ immortal strand hypothesis has met with consterna-
tion, skepticism, and outright ridicule. It certainly meets the
criteria for a bold, new disruptive idea. Though I had no interest
in reading Cairns’ paper when it was assigned to my undergradu-
ate Biochemistry course before he arrived as a guest lecturer in the
spring of 1978 at Harvard College, in later years I would develop
the first theoretical estimate of the extent to which tissue stem cells
might lower their mutation rate compared to their differentiating
progeny cells (Sherley, 2006); and I would become driven to pur-
sue and promote research to discover the responsible molecular
mechanisms. It is my hope that “Stem Cell Genetic Fidelity” will
in some measure contribute to this purpose.
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